Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF in Pregnant Women With Chronic Hepatitis B Infection
NCT04507607Phase 1Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tenofovir alafenamide in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Liver indicators of intrapartum and Liver indicators of postpartum. Status: unknown.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04507607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507607.